# Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance

Study · id `cardio:ct-nct04071613` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04071613](<https://clinicaltrials.gov/study/NCT04071613>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04071613

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

## Technical summary

Registry record NCT04071613. Randomized; single masking; primary purpose treatment. Start 2019-06-20 (actual); primary completion 2021-11-16 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 104 participants (enrolled count; ClinicalTrials.gov record NCT04071613, source copy `cardio:ctgov-nct04071613-2021-12-08`, retrieved 2026-10-26)
- Started: 2019-06-20 (actual) (ClinicalTrials.gov record NCT04071613, source copy `cardio:ctgov-nct04071613-2021-12-08`, retrieved 2026-10-26)
- Primary completion: 2021-11-16 (actual) (ClinicalTrials.gov record NCT04071613, source copy `cardio:ctgov-nct04071613-2021-12-08`, retrieved 2026-10-26)
- Completion: 2021-11-16 (actual) (ClinicalTrials.gov record NCT04071613, source copy `cardio:ctgov-nct04071613-2021-12-08`, retrieved 2026-10-26)
- Countries: Australia (ClinicalTrials.gov record NCT04071613, source copy `cardio:ctgov-nct04071613-2021-12-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04071613-2021-12-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance
- Acronym: TASTEa
- Condition: Stroke, Acute, Stroke Ischemic
- Intervention (Drug): Tenecteplase
- Intervention (Drug): Intravenous tissue plasminogen activator (tPA)
- Lead sponsor: Melbourne Health
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial (`cardio:pubmed-35525251`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3e4f33d9e7ea1499736a3861e082db4204728199b5cb0a0aa36bd4f4d46c8ee5
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
